The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Express News | Ibio Inc - Enters Exclusive License Agreement With Astralbio
IBio Expands Cardiometabolic and Obesity Pipeline Through Licensing of First-in-Class Antibody Targeting Activin E From AstralBio
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
12 Health Care Stocks Moving In Monday's Intraday Session
IBio's Non-GLP Non-human Primate Pharmacokinetics Study Suggests IBIO-600, Anti-myostatin Antibody Designed For Subcutaneous Administration, Could Provide A Significantly Extended Half-life In Humans And A Weight Loss Treatment Option While Preserving...
Express News | Ibio Inc - on Track for Regulatory Submission for Ibio-600 in Q1 2026
Express News | Ibio Announces Ibio-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim in Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
IBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
IBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025
Crisis and Redemption: The Darkest Moment and Dawn of the Vaccine Industry.
The vaccine Industry is currently facing challenges, but its fate is not simply a one-way decline.
Express News | CORRECTION: Impact BioMedical Ticker Is "IBO"
Express News | Impact BioMedical Shares Resume Trade
$IBIO Stock Is up 12% Today. Here's What We See in Our Data.
IBio: to Begin Trading on the Nasdaq Stk Exchange
IBio: Expects to Begin Trading as a Nasdaq-Listed Co on Mar 4, Continue to Trade Under 'IBIO' >IBIO
IBio: Stk Approved for Listing on Nasdaq Cap Market, Will Transfer Listing to Nasdaq From NYSE Amer >IBIO
Express News | Ibio to Begin Trading on the Nasdaq Stock Exchange
IBio to Begin Trading on the Nasdaq Stock Exchange
Ibio Inc Faces Financial Risk From Potential Stockholder Equity Dilution and Capital Raising Challenges